A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People
Clinical trial NCT03812198 · COMPLETED
Trial details
- NCT number
- NCT03812198
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2019-06-13
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.